TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Penguins notebook: Malkin picture muddy
  2. Pirates notebook: Martin feels ‘pretty good,’ will start vs. Giants
  3. NFL notebook: Raiders name Sparano interim coach
  4. Steelers film session: Harrison on the field often
  5. Steelers notebook: Tomlin bringing officials to practice
  6. I-79 line painting begins Thursday
  7. Shareholders cheer eBay’s decision to spin off PayPal
  8. Virginia kicker says parents preached commitment
  9. Animal Friends receives $1.5 million state grant
  10. Public station WQED cutting staff in face of financial woes
  11. Pittsburgh rallies for second year of Pirates magic
Subscribe today! Click here for our subscription offers.